elliptinium has been researched along with Hemolysis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amiel, JL; Brulé, G; Huertas, D; Le Chevalier, T; Mondésir, JM; Rouëssé, J; Sancho-Garnier, H; Tursz, T | 1 |
Amiel, JL; Brule, G; Callet, B; Droz, JP; Huertas, D; Le Chevalier, T; Le Pecq, JB; Paoletti, C; Rouesse, J; Sancho-Garnier, H; Tursz, T; Voisin, PM | 1 |
Cibas, I; Einzig, AI; Gralla, RJ; Greenberg, E; Kelsen, DP; Lewis, E; Leyland-Jones, BR | 1 |
Amiel, JL; Caille, P; De Jager, R; Le Chevalier, T; May-Levin, F; Mondesir, JM; Rouësse, JG; Sancho-Garnier, H; Spielmann, M | 1 |
1 trial(s) available for elliptinium and Hemolysis
Article | Year |
---|---|
[2 N methyl 9 hydroxy-ellipticine in treatment of metastatic breast cancers (author's transl)].
Topics: Alkaloids; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Ellipticines; Female; Hemolysis; Humans | 1981 |
3 other study(ies) available for elliptinium and Hemolysis
Article | Year |
---|---|
[N-Methyl-9 hydroxy-ellipticine (NSC 264-137) in the treatment of malignant metastases. Preliminary results (author's transl)].
Topics: Alkaloids; Antineoplastic Agents; Breast Neoplasms; Ellipticines; Hemolysis; Humans; Kidney Neoplasms; Neoplasm Metastasis; Sarcoma; Soft Tissue Neoplasms | 1981 |
Phase I study of elliptinium (2-N-methyl-9-hydroxyellipticinium).
Topics: Adolescent; Adult; Aged; Alkaloids; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Evaluation; Ellipticines; Female; Hemolysis; Humans; Male; Middle Aged; Neoplasms; Uremia | 1985 |
Phase II study of elliptinium in advanced breast cancer.
Topics: Acute Kidney Injury; Adult; Aged; Alkaloids; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Ellipticines; Female; Hemolysis; Humans; Immunoglobulin M; Middle Aged; Soft Tissue Neoplasms | 1985 |